Upvote
Downvote
Study Director
Share Job
- Suggest Revision
- is a leading contract research organization with a comprehensive range of services that span from being an outsourcing partner for discovery stage R&D work, a preclinical CRO performing safety efficacy and toxicology studies for small molecules and advanced therapies alike, and, most recently, an expansion into manufacturing services for cell, gene, and mRNbased therapeutics.
- safety, efficacy, and toxicology unit (ASET) was launched as a preclinical CRO that spun out of Battelle in 2021 to address the changing needs of commercial organizations developing modern therapeutics.
- brings decades of experience to accommodate a wide variety of GLP and non-GLP studies in all in vivo models and dose routes.
- has made to empower preclinical assessments of advanced therapies is building a new state-of-the-art analytical laboratory to include molecular and immunological assays that assess critical safety and efficacy indicators for cell and gene therapies during preclinical studies
- on toxicology, biodistribution, pharmacokinetic, and related studies to ensure study execution, client engagement, and deliverables upon study completion.
Expired TodayInactive Job
Similar Job
Relevance
Active